CN Bio launches PhysioMimix Bioavailability assay kit: Human 18
- Unique solution enabling researchers to profile human oral drug bioavailability in vitro, in their own laboratories
- Expands access to CN Bio’s robust multi-organ Gut/Liver-on-a-chip model to accelerate and de-risk clinical progression of drug candidates
- Supports up to 18 data replicates and simulation of both intravenous and oral dosing routes